Related Experiment Video
Updated: Jan 14, 2026
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Brain natriuretic peptide and echocardiographic parameters as biomarkers for predicting new atrial fibrillation
Stefano Forlivesi1, Giovanna De Marco2, Letizia Riva3
1IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurology and Stroke Center, Maggiore Hospital, Bologna, Italy.
Background:
Detection of atrial fibrillation (AF) after ischemic stroke (IS) is crucial for starting anticoagulant therapy to prevent IS recurrence. Strategies to identify patients who might benefit the most from extended electrocardiography (ECG) monitoring would be highly desirable.
Objectives:
We aimed to investigate the role of brain natriuretic peptide (BNP) and echocardiographic parameters as biomarkers for predicting new AF detection in a large cohort of patients with acute IS.
Design:
We retrospectively analyzed data of 2411 consecutive patients admitted for IS to a single Stroke Center from January 1, 2018, to May 31, 2023.
Methods:
BNP levels were measured within 48 h of onset. Clinical and echocardiographic variables were evaluated. Single or multiple 12-lead ECG and continuous monitoring with external or implantable devices were used to detect new AF. The outcome measure was new AF detection at 3 months.
Results:
Of 2337 included patients, 1907 (81.6%) had not previously known AF, and new AF was detected in 422 (22%) patients. In the multivariate analysis, older age (odds ratio (OR) 1.03, 95% confidence interval (CI) 1.02-1.05, p < 0.001), higher National Institutes of Health Stroke Scale score (OR 1.05, 95% CI 1.03-1.07, p < 0.001), BNP ⩾150 pg/ml (OR 4.10, 95% CI 2.95-5.69, p < 0.001), and left atrium (LA) enlargement (OR 2.88, 95% CI 1.99-4.18, p < 0.001) were independently associated with new AF detection. The combination of both BNP ⩾150 pg/ml and LA enlargement showed a strong association (adjusted OR 4.74, 95% CI 3.47-6.48, p < 0.001) and a good discriminative performance for predicting new AF detection at 3 months (area under the receiver operating characteristic curve 0.74, 95% CI 0.71-0.77, sensitivity 0.70 (95% CI 0.65-0.74), specificity 0.78 (95% CI 0.76-0.80)).
Conclusion:
BNP ⩾150 pg/ml within 48 h of IS onset and LA enlargement, especially if combined, may be valuable biomarkers for predicting new AF detection and identifying patients who might benefit the most from extended ECG monitoring.
More Related Videos
07:41Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:30Dysrhythmias V: Evaluating Dysrhythmias